Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
279 studies found for:    Hair Diseases
Show Display Options
Rank Status Study
1 Recruiting AGA Biocellular Stem/Stromal Hair Regenerative Study
Condition: Hair Disease
Interventions: Procedure: Intradermal Injection in hair loss;   Procedure: Platelet Rich Plasma;   Procedure: Adipose Derived Stem/Stromal Cells;   Procedure: Stem/Stromal Cellular Isolation (Digestive);   Procedure: MatriStem Matrix (ACell) - Current Standard of Care;   Procedure: HD-PRP (High Density Platelet Rich Plasma);   Procedure: Emulsified AD-tSVF;   Procedure: Emulsified AD-cSVF
2 Completed Low Fluence 1064nm Laser Hair Reduction for Pseudofolliculitis Barbae in Skin Types IV, V, VI
Condition: Pseudofolliculitis Barbae
Intervention: Procedure: 1064nm Nd:YAG laser at 12 J/cm2, 20 ms and 10mm spot size.
3 Completed Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae
Condition: Pseudofolliculitis Barbae
Intervention: Drug: 15% Eflornithine Hdyrochloride
4 Recruiting EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors
Condition: Alopecia
Interventions: Other: CG428;   Other: Placebo
5 Recruiting Point-of-Care Adipose-derived Cells for Hair Growth
Condition: Androgenetic Alopecia
Interventions: Procedure: Stromal Vascular Fraction Cells (SVF Cells) Injection;   Procedure: Liposuction;   Other: Hair Measurements
6 Completed Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair
Condition: Hypertrichosis
Intervention: Device: Prowave LX IPL
7 Terminated A Prospective Multi-Center Study of a Novel Dual-Wavelength Laser for Hair Removal
Condition: Hypertrichosis
Intervention: Device: 755nm and 1064nm Nd:YAG laser
8 Completed
Has Results
Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
Condition: Hypertrichosis
Interventions: Device: Soprano/SHR;   Device: LightSheer
9 Recruiting Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan
Condition: Eyelash Hypotrichosis
Intervention: Drug: Bimatoprost cutaneous solution 0.03%
10 Completed Minoxidil 1% for Eyebrow Enhancement
Conditions: Eyebrow Hypotrichosis;   Thin Eyebrow
Interventions: Drug: Minoxidil lotion 1%;   Drug: Placebo
11 Completed Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows
Condition: Hypotrichosis
Interventions: Drug: Track A;   Drug: Track B
12 Completed
Has Results
Bimatoprost for the Treatment of Eyebrow Hypotrichosis
Condition: Eyebrow Hypotrichosis
Interventions: Drug: bimatoprost solution;   Drug: Vehicle to bimatoprost solution
13 Completed
Has Results
Bimatoprost in the Treatment of Eyelash Hypotrichosis
Condition: Idiopathic Eyelash Hypotrichosis
Interventions: Drug: bimatoprost formulation A solution;   Drug: bimatoprost solution 0.03 %;   Drug: vehicle of bimatoprost formulation A solution;   Drug: vehicle of bimatoprost solution 0.03 %
14 Completed Minoxidil 2% for Eyebrow Enhancement
Conditions: Hypotrichosis of Eyebrows;   Thinning Eyebrows
Interventions: Drug: Minoxidil lotion 2%;   Drug: Placebo
15 Completed
Has Results
An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
Condition: Eyelash Hypotrichosis
Intervention: Drug: bimatoprost 0.03%
16 Completed
Has Results
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
Condition: Hypotrichosis
Interventions: Drug: bimatoprost ophthalmic solution 0.03%;   Drug: bimatoprost vehicle solution
17 Completed
Has Results
Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis
Condition: Eyelash Hypotrichosis
Interventions: Drug: bimatoprost solution 0.03%;   Drug: bimatoprost vehicle solution
18 Completed
Has Results
Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis
Condition: Eyelash Hypotrichosis
Interventions: Drug: bimatoprost solution 0.03%;   Drug: bimatoprost vehicle solution
19 Completed Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo
Condition: Hypotrichosis
Intervention: Drug: topical bimatoprost
20 Suspended Evaluation of Efficacy and Comparative Isolation of the Association Beclomethasone Clotrimzaol + + Gentamicin in Patients With Acne Contaminated
Condition: Folliculitis
Interventions: Drug: Clotrimazole + Gentamicin + Beclomethasone;   Drug: Clotrimazole + Gentamicin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.